pharma
“Radical radiotherapy” cuts required treatments from 37 to 5
August 14, 2018Manufacturing and Production Cancer, oncology, pharma, radiotherapy
Researchers at Queen’s University Belfast have been trialling a new form of “radical radiotherapy” which can be delivered in just …
Working Life: Nawal Ouzren, CEO of Sensorion
August 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Sensorion, Working Life, feature, pharma
Pharmafocus caught up with Sensorion CEO Nawal Ouzren to take a look at her path throughout her career and get …
Indicted GOP congressman Chris Collins’ terminates re-election campaign
August 13, 2018Medical Communications, Sales and Marketing Chris Collins, Innate Therapeutics, US, pharma
Indicted republican congressman Chris Collins has performed a U-turn since his arrest on Wednesday under allegations of insider trading, confirming …
FDA approves first oral therapy for rare Fabry disease
August 13, 2018Sales and Marketing FDA, Fabry disease, US, pharma
Amicus has revealed that its therapy Galafold (migalastat) has been awarded approval by the FDA in the treatment of adult …
NHS scraps restriction on availability of J&J’s Imbruvica in leukaemia patients
August 10, 2018Medical Communications, Sales and Marketing Cancer, J&J, JJ, Johnson & Johnson, NHS, NICE, UK, imbruvica, leukaemia, pharma
The NHS has dropped a controversial restriction preventing leukaemia patients from accessing Johnson & Johnson’s tyrosine kinase inhibitor Imbruvica (ibrutinib), …
Top Ten most popular articles on Pharmafile.com this week
August 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ADHD, Allergan, MHRA, UK, brexit, iraq, pharma, top 10
There was some clarity on Brexit this week as the MHRA set out a plan for the implantation period set …
FDA approved more generics in July than any previous month
August 10, 2018Medical Communications FDA, generics, pharma
FDA Commissioner Scott Gottlieb took to Twitter to announce the news that the FDA smashed its previous record for number …
US Congressman arrested over insider trading in biopharma firm
August 9, 2018Research and Development, Sales and Marketing Chris Collins, Innate, Innate Immunotherapeutics, US, congress, multiple sclerosis, pharma
A Republican Congressman has been arrested by the FBI over on charges of insider trading with shares in Australian biopharmaceutical …
NICE recommends Pfizer’s Besponsa in rare leukaemia following review
August 9, 2018Sales and Marketing NICE, Pfizer, leukaemia, pharma
Pfizer has revealed that NICE has finally decided to recommend its CD22-targeting monoclonal antibody Besponsa (inotuzumab ozogamicin) in the treatment …
Insys Therapeutics reaches $150m agreement to settle opioid marketing case
August 9, 2018Medical Communications, Sales and Marketing Litigation, Subsys, US Department of Justice, fentanyl, insys, opioid, pharma
The Arizona-based pharma company Insys Therapeutics has reached an agreement to pay $150 million to the US Department of Justice …
AstraZeneca to pay $110m to settle allegations of fraudulent marketing in Texas
August 8, 2018Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Texaas, US, pharma
AstraZeneca has backed down in a dispute with the State of Texas over allegations it had defrauded the state’s Medicaid …
MSD’s experimental vaccine to be used in fight against Congo Ebola outbreak
August 8, 2018Research and Development Congo, Ebola, MSD, Merck, Vaccine, pharma
MSD’s experimental drug rVSV-ZEBOV will be used in tackling the latest Ebola outbreak in the Democratic Republic of Congo, after …
Strong efficacy but serious side-effects with Spark’s haemophilia drug drop shares by 30%
August 8, 2018Research and Development Spark Therapeutics, haemophilia, pharma
Spark Therapeutics has been left reeling after it revealed new data on its haemophilia A treatment, which, while promising in …
Ironwood returns US Zurampic rights to AstraZeneca, announces operational cuts
August 7, 2018Manufacturing and Production, Sales and Marketing AstraZeneca, Ironwood, Zurampic, gout, pharma
Ironwood Pharmaceuticals has revealed that it has taken the decision to hand the rights for gout therapy Zurampic (lesinurad) back …
Pain Therapeutics refocuses on Alzheimer’s after FDA turns down abuse-deterrent opioid painkiller
August 7, 2018Manufacturing and Production, Research and Development, Sales and Marketing FDA, Remoxy, opioid crisis, opioids, pain therapeutics, pharma
The FDA has voted to reject Texas-based Pain Therapeutics’ abuse deterrent opioid painkiller Remoxy (oxycodone), leading the company to consider …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
